Biallelic RPE65 Mutation-associated Retinal Dystrophy
2 clinical trials · Condition
◉ Watch Biallelic RPE65 Mutation-associated Retinal Dystrophy
| Record | Firm | Date |
|---|---|---|
| Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy (NCT05858983) | Frontera Therapeutics | 2022-11-30 |
| Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy (NCT04516369) | Novartis Pharmaceuticals | 2020-11-24 |
Track Biallelic RPE65 Mutation-associated Retinal Dystrophy automatically
Every clearance here is in the API, with alerts when new ones post.